Reckitt Benckiser Buys Into OTC Cough/Cold Category
Reckitt Benckiser has agreed to buy Adams Respiratory Therapeutics, the manufacturer of Mucinex and Delsym, for $2.3 billion.
MORE ON THIS STORY...
MORE RETAIL NEWS HEADLINES...
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!
©2020 RetailWire LLC. All rights reserved.